WDR31

Across TCGA pan-cancer cohorts, WDR31 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated WDR31 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher WDR31 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated WDR31 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

LUAD, PRAD, and UCEC are the cancer types where WDR31 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.090	0.812	<.001	24	view →
PRAD	DFS	Median	All	0.157	0.888	<.001	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
BLCA	OS	Median	II,III,IV	1.000	0.412	.040	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

WDR31–LUAD (OS)

Open the LUAD breakdown →